Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- Prof. Richard Hobbs, MD
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
- Prof. Lars Rydén
Lecture: Diabetes: The new challenge in cardiovascular risk management
Lecture: Diabetes: The new challenge in cardiovascular risk management
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Diabetes: The new challenge in cardiovascular risk management
- Prof. Lars Rydén
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
- Prof John E Deanfield